Optimal Research   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Peoria IL United States (1999)

Organization Overview

First Clinical Trial
2006
NCT00468273
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Optimal Research | Optimal Research (Just In Time sites) - other USA study locations can be available on demand, please contact optimalcommunity@optimaljit.com | Optimal Research LLC | Optimal Research, LLC | Optimed Research LLC

Active Ingredients

Drugs in Phase 3 Trials (3)

acetaminophen (tylenol) (1 trial)

ibuprofen (motrin) (1 trial)

immune globulin (human) (Gamastan) (1 trial)

Drugs in Phase 2 Trials (4)

debio-1347 (1 trial)

ethanol (1 trial)

glycolic acid (1 trial)

nasovax (1 trial)

Drugs in Phase 1 Trials (1)

ebola vaccine (Ervebo) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhagic Fever, Ebola (Phase 1)

Herpes Labialis (Phase 2)

Immunologic Deficiency Syndromes (Phase 3)

Neoplasms (Phase 2)

Pain, Postoperative (Phase 3)

Syndrome (Phase 3)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 8